VaramirStart free · no cardSign in
LNTH as of Oct 31 · 19:31 ET
LNTHNasdaqIn Vitro & In Vivo Diagnostic Substances

Lantheus Holdings, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±11.9%
avg realized
±11.0%
Jan 28 '25±8.0%▼−7.30%×0.91
Feb 26 '25±16.3%▲+16.49%×1.01
May 7 '25±12.2%▼−23.23%×1.90
Aug 6 '25±12.2%▼−28.58%×2.34
Nov 6 '25±18.5%▼−6.19%×0.34
Q1 FY26±13.1%▼−0.38%×0.03
May 7 '26±10.5%▲+5.63%×0.53
Q2 FY26±4.6%▼−0.42%×0.09
quarterimplied−30%0+30%realized×
Q2 FY26±4.6%▼−0.42%×0.09
May '26±10.5%▲+5.63%×0.53
Q1 FY26±13.1%▼−0.38%×0.03
Nov '25±18.5%▼−6.19%×0.34
Aug '25±12.2%▼−28.58%×2.34
May '25±12.2%▼−23.23%×1.90
2 older reports
Feb '25±16.3%▲+16.49%×1.01
Jan '25±8.0%▼−7.30%×0.91
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

11disclosed supplier and customer ties in SEC filingsSEC filings
6tracked funds holding LNTHN-PORT · Aug 31 '26

Bear2

5 of 8recent reports where the move came in under the options implied rangeEarnings history
4 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

LNTH report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±2.0% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.